A Follow-up Study on Safety and Tolerability and Pharmacodynamic Effect, of Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Who Have Previously Been Treated With sNN0031, Using an Implanted Catheter and a SynchroMed II Pump [FOLLOW-UP TO 700030728]

Trial Profile

A Follow-up Study on Safety and Tolerability and Pharmacodynamic Effect, of Patients With Idiopathic Parkinson's Disease (PD) of Moderate Severity, Who Have Previously Been Treated With sNN0031, Using an Implanted Catheter and a SynchroMed II Pump [FOLLOW-UP TO 700030728]

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs SNN 0031 (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Medtronic
  • Most Recent Events

    • 08 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov .
    • 01 Jul 2014 Planned End Date changed from 1 Aug 2013 to 1 Aug 2014 according to ClinicalTrials.gov record.
    • 01 Jul 2014 Planned primary completion date changed from 1 Aug 2013 to 1 Nov 2013 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top